Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,384.80
-14.00 (-1.00%)
At close: Aug 8, 2025
Emcure Pharmaceuticals Company Description
Emcure Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products worldwide.
It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, VMN, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.
It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Orofer FCM, and Proxym brand names.
Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Emcure Pharmaceuticals Limited
| Country | India |
| Founded | 1981 |
| Industry | Pharmaceutical Preparations |
| Employees | 6,731 |
| CEO | Satish Mehta |
Contact Details
Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India | |
| Phone | 91 20 3507 0033 |
| Website | emcure.com |
Stock Details
| Ticker Symbol | 544210 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Satish Mehta | Chief Executive Officer |
| Tajuddin Shaikh | Chief Financial Officer |
| Samit Mehta | Chief Operating Officer |